What WALGREEN CO's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Open-market sale · S | −1,900 | $74.85 | −$142K | 78,974 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Open-market sale · S | −11,689 | $73.74 | −$862K | 80,874 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Exercise / conversion · M | +13,589 | $27.69 | +$376K | 92,563 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Open-market sale · S | −2,600 | $74.70 | −$194K | 78,974 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Open-market sale · S | −10,990 | $73.43 | −$807K | 81,574 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Exercise / conversion · M | +13,590 | $27.69 | +$376K | 92,564 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Open-market sale · S | −2,600 | $74.69 | −$194K | 78,974 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Open-market sale · S | −10,990 | $73.43 | −$807K | 81,574 |
| Wilson-Thompson Kathleen | SVP and Chief HRO | Dec 15 | Exercise / conversion · M | +13,590 | $27.69 | +$376K | 92,564 |
| Theriault Timothy J | Senior Vice President | Dec 15 | Exercise / conversion · M | +10,688 | $35.65 | +$381K | 128,440 |
| Theriault Timothy J | Senior Vice President | Dec 12 | Open-market sale · S | −27,997 | $74.50 | −$2.09M | 117,752 |
| Theriault Timothy J | Senior Vice President | Dec 12 | Exercise / conversion · M | +27,997 | $35.65 | +$998K | 145,749 |
| Foote William C | Director | Nov 19 | Gift · G | −7,500 | — | — | 37,823 |
| Wasson Gregory D | President and CEO | Nov 12 | Gift · G | −15,000 | — | — | 447,118 |
| Crawford Kermit R | EVP, Pharm., Health & Wellness | Nov 07 | Open-market sale · S | −53,366 | $66.35 | −$3.54M | 83,504 |
| Crawford Kermit R | EVP, Pharm., Health & Wellness | Nov 07 | Exercise / conversion · M | +53,366 | $35.65 | +$1.9M | 136,870 |
| Crawford Kermit R | EVP, Pharm., Health & Wellness | Nov 07 | Open-market sale · S | −30,778 | $66.26 | −$2.04M | 83,504 |
| Crawford Kermit R | EVP, Pharm., Health & Wellness | Nov 07 | Exercise / conversion · M | +30,778 | $34.04 | +$1.05M | 114,282 |
| Crawford Kermit R | EVP, Pharm., Health & Wellness | Nov 07 | Open-market sale · S | −23,552 | $66.26 | −$1.56M | 83,504 |
| Crawford Kermit R | EVP, Pharm., Health & Wellness | Nov 07 | Exercise / conversion · M | +23,552 | $36.43 | +$858K | 107,056 |
Loading...